Sernova Corp T.SVA

Viacycte reports positive results from study

[MustangSalley]

https://www.prnewswire.com/news-releases/viacytes-stem-cell-derived-treatment-for-type-1-diabetes-shows-promising-results-in-two-published-studies-301436100.html Viacycte's results published in two scientific journals. Maybe Frank Hollar can volunteer to be the 7 th patient

[Redbaron2211]

Nice to see Viacyce getting some exposure but what they have published so far isn't really anything to get excited about.   After 6 months on immunosuppression some patients indicate positive C-peptide?  Was this found in the blood?  Because Viacyte did not include an absence of C-peptide as part of the Inclusion Criteria in their clinical trial I would question the

[Metalsguy1]

Red. The results are especially unimpressive given that the standard of care target range is 70 to 180. If the average is above 150ish, the A1C would still be above 7.

[Redbaron2211]

That's true another example of a likely failure hidden behind a vague description of results.  Sigilon is also pretty much out of the picture. Vertex at least has some decent 90 day data on the first patient but from my understanding they are just injecting into the portal vein with immunosuppression and are way behind anyways.  "Day 90, HbA1c improved from 8.6% at baseline

[Metalsguy1]

On the surface the promotion of FH appears to be positive to the uninformed but at a deeper level it could mean that even the Board has recognized that management is not getting the job done in terms of deals.

[Redbaron2211]

Its possible but my gut feeling is they have a licensing deal and Hollar is onboarding because things are about to get real. 

[Metalsguy1]

Given the number of people here who have spoken to management and come away with the idea a deal is in the works and imminent I think it's more covering of incompetence.